Internal Medicine, Hematology & Oncology · Springfield, IL
NPI
1699702316
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
415 N 9th St, 2w106
Springfield, IL, 62702
Phone (217) 545-5817
Groups this clinician bills Medicare through
Medicare paid, 2024
$778K
58,487 services
Medicare patients, 2024
385
Average age 73
Drug cost, 2024
$3.5M
652 prescriptions
Company payments, 2024
$97.98
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aziz Khan was code J2405 (injection, ondansetron hydrochloride, per 1 mg), 2,032 times for 21 patients. In total Aziz Khan billed 58,487 services in 94 codes, and Medicare paid $778K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 2,032 | 21 | $0.07 | $149 |
| J0897 Injection, denosumab, 1 mg | Office | 1,980 | 12 | $20.20 | $40K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,112 | 25 | $0.09 | $100 |
| 99214 Office E&M - Established | Office | 513 | 293 | $90.87 | $47K |
| 96367 Intravenous Infusion, Hydration | Office | 201 | 24 | $21.54 | $4,329 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 196 | 12 | $0.40 | $78.69 |
| 96375 Injection Administration | Office | 196 | 26 | $11.80 | $2,313 |
| 96413 Chemotherapy Administration | Office | 170 | 39 | $95.93 | $16K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 101 | 20 | $4.00 | $404 |
| 96372 Injection Administration | Office | 88 | 36 | $10.96 | $964 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 75 | 18 | $0.64 | $48.37 |
| J3490 Unclassified drugs | Office | 67 | 19 | $0.53 | $35.76 |
| 96523 Chemotherapy | Office | 65 | 28 | $16.72 | $1,087 |
| 36591 Vascular | Office | 40 | 19 | $20.78 | $831 |
| 96365 Intravenous Infusion, Hydration | Office | 40 | 34 | $40.80 | $1,632 |
By year: 2022 $1.4M for 81,011 services; 2023 $729K for 46,343 services; 2024 $778K for 58,487 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aziz Khan prescribed most often to Medicare patients was Anastrozole, with 50 prescriptions and refills. In total Aziz Khan wrote 652 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 50 | 142 | 18 | $555 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 43 | 43 | 16 | $1,071 |
| Letrozole Generic | 40 | 101 | 14 | $626 |
| Imatinib Mesylate Generic | 36 | 44 | Under 11 | $148K |
| Eliquis Apixaban | 31 | 49 | Under 11 | $29K |
| Xtandi Enzalutamide | 27 | 41 | Under 11 | $581K |
| Imbruvica Ibrutinib | 25 | 25 | Under 11 | $408K |
| Morphine Sulfate Er Morphine Sulfate | 24 | 24 | Under 11 | $873 |
| Abiraterone Acetate Generic | 20 | 32 | Under 11 | $47K |
| Lonsurf Trifluridine/Tipiracil Hcl | 18 | 18 | Under 11 | $173K |
| Ondansetron Hcl Generic | 15 | 15 | Under 11 | $124 |
| Doptelet Avatrombopag Maleate | 15 | 26 | Under 11 | $353K |
| Venclexta Venetoclax | 15 | 15 | Under 11 | $177K |
| Deferiprone (3 Times A Day) Deferiprone | 13 | 13 | Under 11 | $198K |
| Ibrance Palbociclib | 13 | 13 | Under 11 | $197K |
Brand drugs: 216 claims; generic drugs: 436 claims; opioid claims: 78.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Aziz Khan $97.98 ($97.98 in general payments such as food, travel and fees) from 1 company. The largest payer was Incyte Corporation with $97.98.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 1 | $97.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.